250 related articles for article (PubMed ID: 22516549)
1. Chromosomal anomalies and prognostic markers for intracranial and spinal ependymomas.
Yang I; Nagasawa DT; Kim W; Spasic M; Trang A; Lu DC; Martin NA
J Clin Neurosci; 2012 Jun; 19(6):779-85. PubMed ID: 22516549
[TBL] [Abstract][Full Text] [Related]
2. Genetic expression profiles of adult and pediatric ependymomas: molecular pathways, prognostic indicators, and therapeutic targets.
Nagasawa DT; Trang A; Choy W; Spasic M; Yew A; Zarinkhou G; Garcia HM; Yang I
Clin Neurol Neurosurg; 2013 Apr; 115(4):388-99. PubMed ID: 23374238
[TBL] [Abstract][Full Text] [Related]
3. Overview of recent advances in the classification of ependymomas in WHO CNS5 classification: Simplified approach to their integrated diagnosis.
Gupta RK; Sharma A; Sharma MC
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S68-S72. PubMed ID: 35562136
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of chromosome 1q gain in intracranial ependymomas.
Rajeshwari M; Sharma MC; Kakkar A; Nambirajan A; Suri V; Sarkar C; Singh M; Saran RK; Gupta RK
J Neurooncol; 2016 Apr; 127(2):271-8. PubMed ID: 26725097
[TBL] [Abstract][Full Text] [Related]
5. Pediatric Ependymoma.
Vitanza NA; Partap S
J Child Neurol; 2016 Oct; 31(12):1354-66. PubMed ID: 26503805
[TBL] [Abstract][Full Text] [Related]
6. Ependymomas in Children and Adults.
Lampros M; Vlachos N; Alexiou GA
Adv Exp Med Biol; 2023; 1405():99-116. PubMed ID: 37452936
[TBL] [Abstract][Full Text] [Related]
7. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma.
Mendrzyk F; Korshunov A; Benner A; Toedt G; Pfister S; Radlwimmer B; Lichter P
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2070-9. PubMed ID: 16609018
[TBL] [Abstract][Full Text] [Related]
8. Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade.
Rousseau A; Idbaih A; Ducray F; Crinière E; Fèvre-Montange M; Jouvet A; Delattre JY
J Neurooncol; 2010 May; 97(3):353-64. PubMed ID: 19865800
[TBL] [Abstract][Full Text] [Related]
9. Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival.
Lukashova-v Zangen I; Kneitz S; Monoranu CM; Rutkowski S; Hinkes B; Vince GH; Huang B; Roggendorf W
Acta Neuropathol; 2007 Mar; 113(3):325-37. PubMed ID: 17265049
[TBL] [Abstract][Full Text] [Related]
10. Pediatric spinal ependymoma with chromothripsis of chromosome 6: a case report and review of the literature.
Scott KR; Gener MA; Repnikova EA
J Med Case Rep; 2024 Feb; 18(1):95. PubMed ID: 38351155
[TBL] [Abstract][Full Text] [Related]
11. Surgical outcomes in spinal cord ependymomas and the importance of extent of resection in children and young adults.
Safaee M; Oh MC; Mummaneni PV; Weinstein PR; Ames CP; Chou D; Berger MS; Parsa AT; Gupta N
J Neurosurg Pediatr; 2014 Apr; 13(4):393-9. PubMed ID: 24506340
[TBL] [Abstract][Full Text] [Related]
12. Ependymoma: Evaluation and Management Updates.
Rudà R; Bruno F; Pellerino A; Soffietti R
Curr Oncol Rep; 2022 Aug; 24(8):985-993. PubMed ID: 35384591
[TBL] [Abstract][Full Text] [Related]
13. Genetic differences on intracranial versus spinal cord ependymal tumors: a meta-analysis of genetic researches.
Lee CH; Chung CK; Kim CH
Eur Spine J; 2016 Dec; 25(12):3942-3951. PubMed ID: 27637901
[TBL] [Abstract][Full Text] [Related]
14. Genetics of nervous system tumors.
Shapiro JR
Hematol Oncol Clin North Am; 2001 Dec; 15(6):961-77. PubMed ID: 11770302
[TBL] [Abstract][Full Text] [Related]
15. Prognosis by tumor location in adults with spinal ependymomas.
Oh MC; Kim JM; Kaur G; Safaee M; Sun MZ; Singh A; Aranda D; Molinaro AM; Parsa AT
J Neurosurg Spine; 2013 Mar; 18(3):226-35. PubMed ID: 23311515
[TBL] [Abstract][Full Text] [Related]
16. Ependymomas of the adult: molecular biology and treatment.
Rudà R; Gilbert M; Soffietti R
Curr Opin Neurol; 2008 Dec; 21(6):754-61. PubMed ID: 18989122
[TBL] [Abstract][Full Text] [Related]
17. Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups.
Hirose Y; Aldape K; Bollen A; James CD; Brat D; Lamborn K; Berger M; Feuerstein BG
Am J Pathol; 2001 Mar; 158(3):1137-43. PubMed ID: 11238062
[TBL] [Abstract][Full Text] [Related]
18. Genomic characterization of ependymomas reveals 6q loss as the most common aberration.
Olsen TK; Gorunova L; Meling TR; Micci F; Scheie D; Due-Tønnessen B; Heim S; Brandal P
Oncol Rep; 2014 Aug; 32(2):483-90. PubMed ID: 24939246
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Long Noncoding RNA HOTAIR Is a Unique Epigenetic Characteristic of Myxopapillary Ependymoma.
Zheng H; Baranova K; Song J; Yan L; Biswas S; Chakrabarti S; Zhang Q
J Neuropathol Exp Neurol; 2020 Nov; 79(11):1193-1202. PubMed ID: 32940681
[TBL] [Abstract][Full Text] [Related]
20. Advances in the classification and treatment of pediatric brain tumors.
Fangusaro J; Bandopadhayay P
Curr Opin Pediatr; 2021 Feb; 33(1):26-32. PubMed ID: 33278109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
